group V PLA₂ Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of group V PLA₂ monoclonal antibodies for advanced research in lipid metabolism and inflammation. Group V PLA₂ monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Group V phospholipase A₂ enzymes catalyze the hydrolysis of phospholipids, releasing fatty acids and lysolipids that act as key mediators in inflammatory responses and cell signaling pathways. Group V PLA₂ activity influences numerous physiological and pathological processes, including neurodegeneration, cancer progression, and cardiovascular diseases. Research focused on group V PLA₂ continues to reveal new insights into cellular mechanisms and potential therapeutic targets. Understanding group V PLA₂ function is crucial for developing effective treatments targeting phospholipid-related pathways. Investigating group V PLA₂ mechanisms provides valuable insights into inflammatory diseases and potential therapeutic interventions. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of lipid metabolism and its impact on human health.